Stocks and Investing
Stocks and Investing
Mon, November 6, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sumant Kulkarni Maintained (ACAD) at Strong Buy with Increased Target to $40 on, Nov 6th, 2023
Sumant Kulkarni of Canaccord Genuity, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Increased Target from $38 to $40 on, Nov 6th, 2023.
Sumant has made no other calls on ACAD in the last 4 months.
There are 10 other peers that have a rating on ACAD. Out of the 10 peers that are also analyzing ACAD, 4 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $31 on, Friday, November 3rd, 2023
- Julio Romero of "JP Morgan" Maintained at Hold with Increased Target to $29 on, Monday, August 7th, 2023
- Jay Olson of "Oppenheimer" Reiterated at Hold and Held Target at $25 on, Thursday, August 3rd, 2023
- Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $27 on, Friday, July 14th, 2023
These are the ratings of the 6 analyists that currently disagree with Sumant
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $33 on, Friday, November 3rd, 2023
- Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $42 on, Friday, November 3rd, 2023
- Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $33 on, Tuesday, October 17th, 2023
- Tessa Romero of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $32 on, Tuesday, October 10th, 2023
- Sarah James of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $42 on, Tuesday, August 22nd, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $33 on, Thursday, August 3rd, 2023
Contributing Sources